晨光生物(300138.SZ):全資子公司擬與鑫淼木業在新疆葉城新設公司
格隆匯4月13日丨晨光生物(300138.SZ)公佈,為加快上游原材料資源佈局,公司決定使全資子公司——晨光生物科技集團莎車有限公司(“莎車晨光”)與喀什鑫淼木業有限公司(“鑫淼木業”)共同出資在新疆喀什地區葉城縣新設公司,開展萬壽菊花加工、銷售及相關業務。
2020年4月12日莎車晨光與鑫淼木業、新疆寶隆化工新材料有限公司(“新疆寶隆”)簽署了《葉城縣萬壽菊花加工項目合作協議》(“合作協議”),約定共同出資1162.249萬元(其中:莎車晨光出資813.574萬元,出資比例為70%;鑫淼木業出資348.675萬元,出資比例為30%),在新疆喀什地區葉城縣新設公司,建設一條日加工萬壽菊鮮花250噸的生產線。
鑫淼木業向新設公司提供50畝項目建設用地、600㎡辦公場所,並承諾自合作協議生效至新公司購買前,由新公司無償使用。如因鑫淼木業原因使新公司無法正常使用該土地及房產,受到損失的,由鑫淼木業承擔賠償責任,新疆寶隆為此事項提供連帶保證擔保。
葉城晨龍生物科技有限公司擬註冊的經營範圍:萬壽菊花加工及顆粒銷售;食品添加劑製造、銷售;花卉、蔬菜、堅果、茶葉、香料作物、中藥材、銀杏種植、初加工、銷售;有機肥料及微生物肥料、複合肥料製造、銷售;農藥銷售;自營和代理各類商品和技術的進出口。
此次投資合作投建萬壽菊加工項目,因受行業、市場、原料、環保等外部因素影響,未來可能存在一定經營、管理風險,項目組將憑藉公司在萬壽菊加工提取的技術優勢和管理經驗,運用到新公司的運營管理中,促進該項目的順利開展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.